THE VALUE OF THERAPEUTIC DRUG-MONITORING TO THE PRACTICING PHYSICIAN - AN HYPOTHESIS NEEDING SENSIBLE APPLICATION

被引:11
作者
WATSON, ID [1 ]
THOMSON, AH [1 ]
机构
[1] STOBHILL GEN HOSP,DEPT MATERIA MED,CLIN PHARMACOKINET LAB,GLASGOW G21 3UW,SCOTLAND
关键词
D O I
10.1111/j.1365-2125.1989.tb03553.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:619 / 620
页数:2
相关论文
共 12 条
[1]  
BOOKMAN JL, 1979, J PHARM SCI, V68, P267
[2]  
DESTACHE CJ, 1989, ANN PHARMACOTHER, V23, P33
[3]  
DEZIELEVANS LM, 1986, CLIN PHARMACY, V5, P319
[4]   IMPACT OF A PHARMACOKINETICS CONSULTATION SERVICE ON CLINICAL OUTCOMES IN AN AMBULATORY-CARE EPILEPSY CLINIC [J].
IOANNIDESDEMOS, LL ;
HORNE, MK ;
TONG, N ;
WODAK, J ;
HARRISON, PM ;
MCNEIL, JJ ;
GILLIGAN, BS ;
MCLEAN, AJ .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1988, 45 (07) :1549-1551
[5]  
KOCHWESE.J, 1974, CLIN PHARMACOL THER, V16, P284
[6]   EFFECT OF THEOPHYLLINE PHARMACOKINETIC MONITORING SERVICE ON COST AND QUALITY OF CARE [J].
LEHMANN, CR ;
LEONARD, RG .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1982, 39 (10) :1656-1662
[8]   INDIVIDUALIZING THEOPHYLLINE THERAPY - THE IMPACT OF CLINICAL PHARMACOKINETICS ON PATIENT OUTCOMES [J].
MUNGALL, D ;
MARSHALL, J ;
PENN, D ;
ROBINSON, A ;
SCOTT, J ;
WILLIAMS, R ;
HURST, D .
THERAPEUTIC DRUG MONITORING, 1983, 5 (01) :95-101
[9]   EXPERIENCE IN MONITORING GENTAMICIN THERAPY DURING TREATMENT OF SERIOUS GRAM-NEGATIVE SEPSIS [J].
NOONE, P ;
PARSONS, TMC ;
PATTISON, JR ;
SLACK, RCB ;
GARFIELD.D ;
HUGHES, K .
BRITISH MEDICAL JOURNAL, 1974, 1 (5906) :477-481
[10]   THERAPEUTIC DRUG-MONITORING [J].
SPECTOR, R ;
PARK, GD ;
JOHNSON, GF ;
VESELL, ES .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (04) :345-353